Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-06

Clinical Trial Update: Tranexamic Acid for Alloplastic Breast Reconstruction [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating tranexamic acid for reducing hematoma in alloplastic breast reconstruction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: McMaster University | Conditions: Hematoma Postoperative, Breast Cancer | Phase 3 | Status: UNKNOWN